drugset / Trial / NCT06841978
Intravenous Thrombosis and Patients with Prior Ischemic Stroke Within 3 Months
Phase 3
Not yet recruiting
306 enrolled
Second Affiliated Hospital, School of Medicine, Zhejiang University
RandomizedParallel-groupDouble-blindTreatment
Summary
The primary hypothesis being tested in this trial is that ischemic stroke patients with prior ischemic stroke within 3 months will have improved clinical outcomes when given intravenous thrombolysis compared to standard care.
Timeline
- Start
- 2025-03-01
- Primary completion
- 2027-06-30
- Completion
- 2027-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alteplase | Protein / enzyme biologic | 0.9 mg/kg | Intravenous |
| Subject | Tenecteplase | Protein / enzyme biologic | 0.25 mg/kg | Intravenous |
| Subject | prourokinase | Protein / enzyme biologic | 20 mg | Intravenous |
| Subject | reteplase | Protein / enzyme biologic | 18 mg | Intravenous |